Mrv0541 01261516402D 26 28 0 0 0 0 999 V2000 0.3763 -0.7560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.2837 -0.2197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0675 -0.4260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4387 -1.1685 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.3763 -1.5810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0675 -1.9110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.2837 -2.0760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.0907 -1.9935 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.8052 -1.5810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.8052 -0.7560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.0907 -0.3435 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.5197 -1.9935 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 3.2341 -1.5810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.2341 -0.7560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.5197 -0.3435 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.6640 -1.1499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.4736 -0.9213 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 5.1881 -1.3338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.9026 -0.9213 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 6.6171 -1.3338 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 7.3317 -0.9213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 8.0461 -1.3338 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 5.1881 -2.1588 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 5.9026 -0.0963 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 6.6171 -2.1588 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 7.3317 -0.0964 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3 4 1 0 0 0 0 1 5 1 0 0 0 0 4 6 1 0 0 0 0 2 3 1 0 0 0 0 5 7 1 0 0 0 0 1 2 1 0 0 0 0 6 7 1 0 0 0 0 5 8 2 0 0 0 0 8 9 1 0 0 0 0 9 10 2 0 0 0 0 10 11 1 0 0 0 0 1 11 2 0 0 0 0 9 12 1 0 0 0 0 12 13 2 0 0 0 0 13 14 1 0 0 0 0 14 15 2 0 0 0 0 10 15 1 0 0 0 0 2 16 1 0 0 0 0 7 16 1 0 0 0 0 17 18 1 0 0 0 0 18 19 1 0 0 0 0 19 20 1 0 0 0 0 20 21 1 0 0 0 0 21 22 1 0 0 0 0 18 23 2 0 0 0 0 19 24 1 6 0 0 0 20 25 1 6 0 0 0 21 26 2 0 0 0 0 M END > CHEBI:84507 > varenicline tartrate > A tartrate salt obtained by reaction of varenicline with one equivalent of (R,R)-tartaric acid. A partial agonist for nicotinic cholinergic receptors, it is used as an aid to giving up smoking. > 3 > varenicline monotartrate; CP-526,555-18; CP 526555-18; 7,8,9,10-Tetrahydro-6,10-methano-6H-pyrazino(2,3-h)(3)benzazepine (2R,3R)-2,3-dihydroxybutanedioate > 7,8,9,10-tetrahydro-6H-6,10-methanoazepino[4,5-g]quinoxaline (2R,3R)-2,3-dihydroxysuccinic acid; 7,8,9,10-tetrahydro-6H-6,10-methanoazepino[4,5-g]quinoxalin-8-ium (2R,3R)-3-carboxy-2,3-dihydroxypropanoate > Chantix; Champix > C17H19N3O6 > 361.34930 > 361.12739 > 0 > O[C@H]([C@@H](O)C(O)=O)C(O)=O.C1C2CNCC1c1cc3nccnc3cc21 > InChI=1S/C13H13N3.C4H6O6/c1-2-16-13-5-11-9-3-8(6-14-7-9)10(11)4-12(13)15-1;5-1(3(7)8)2(6)4(9)10/h1-2,4-5,8-9,14H,3,6-7H2;1-2,5-6H,(H,7,8)(H,9,10)/t;1-,2-/m.1/s1 > TWYFGYXQSYOKLK-LREBCSMRSA-N > 375815-87-5 > 14347664 > 375815-87-5 > DB01273 > D06282 > 22993168; 25013685; 25031315; 25545858 $$$$